Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
UBP says oil, long-term yields drive equity sentiment after Fed lifts rates to 4%

UBP says oil, long-term yields drive equity sentiment after Fed lifts rates to 4%

BitgetBitget2026/09/21 17:04
  • Union Bancaire Privée flagged oil prices and long-term yields as the key near-term swing factors for equities and rates.
  • The Fed raised rates 25 bps to 3.75%-4.00% on Sept. 16, framing the move as insurance against energy-driven inflation.
  • FOMC dot plot signaled at least one more hike by December, pushing any easing back to 2028.
  • 10-year Treasury yields ended near 5.00%, with UBP pointing to oil as the main driver of short-term rate moves.
  • Nasdaq 100 rose 0.9% for the week; UBP expects volatility to be short-lived if oil and yields retreat.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Union Bancaire Privee UBP SA published the original content used to generate this news brief on September 21, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11